Medicare Enrolled
Dr. Radhakrishan Gandhi, M.D.
Interventional Cardiology · Newport Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gandhi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gandhi
Dr. Radhakrishan Gandhi is an interventional cardiology specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gandhi performed 3,301 Medicare services across 2,346 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gandhi received a total of $7,632 from 37 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gandhi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 37% volume in CA
$7,632 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,301
Medicare services
Top 37% in CA for interventional cardiology
2,346
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
991 | $107 | $287 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
639 | $12 | $33 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $74 | $203 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
272 | $173 | $474 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
174 | $141 | $370 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
141 | $100 | $221 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
85 | $69 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
76 | $143 | $428 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
64 | $43 | $75 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
60 | $55 | $161 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
48 | $381 | $1,064 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $66 | $154 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
43 | $10 | $119 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
34 | $21 | $66 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $48 | $126 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
33 | $14 | $45 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
26 | $22 | $58 |
| Cardiac catheterization | 26 | $195 | $624 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
25 | $21 | $52 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
24 | $11 | $36 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
20 | $3 | $7 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $21 | $56 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
16 | $62 | $185 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
15 | $788 | $1,682 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
15 | $20 | $53 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
14 | $11 | $36 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
13 | $176 | $470 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
12 | $455 | $1,242 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
11 | $11 | $31 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
11 | $187 | $553 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
11 | $222 | $601 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
9.8% medium
78.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,632
Total received (2018-2024)
Avg $1,090/year across 7 years
Top 47% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,610 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$799
2023
$447
2022
$2,919
2021
$1,157
2020
$343
2019
$938
2018
$1,029
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$185
Novartis Pharmaceuticals Corporation
$172
Janssen Pharmaceuticals, Inc
$98
E.R. Squibb & Sons, L.L.C.
$65
Amgen Inc.
$58
Medtronic, Inc.
$39
Boston Scientific Corporation
$34
ViiV Healthcare Company
$34
AstraZeneca Pharmaceuticals LP
$30
Merck Sharp & Dohme LLC
$24
PFIZER INC.
$23
SCPHARMACEUTICALS INC.
$23
Kestra Medical Technology Services, Inc.
$15
Top 3 companies account for 56.9% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,624
Novartis Pharmaceuticals Corporation
$919
Amgen Inc.
$573
ABIOMED
$538
Baylis Medical Company Inc
$537
Boehringer Ingelheim Pharmaceuticals, Inc.
$369
Janssen Pharmaceuticals, Inc
$337
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$269
AstraZeneca Pharmaceuticals LP
$246
Medtronic, Inc.
$242
PFIZER INC.
$242
Otsuka America Pharmaceutical, Inc.
$181
Merck Sharp & Dohme LLC
$180
Boston Scientific Corporation
$172
E.R. Squibb & Sons, L.L.C.
$167
Amarin Pharma Inc.
$162
Alnylam Pharmaceuticals Inc.
$96
SANOFI-AVENTIS U.S. LLC
$94
Regeneron Healthcare Solutions, Inc.
$71
Bardy Diagnostics, Inc.
$64
Biohaven Pharmaceutical Holding Company Ltd.
$54
Novo Nordisk Inc
$48
Biosense Webster, Inc.
$44
Kestra Medical Technology Services, Inc.
$43
ZOLL Circulation Inc
$38
Edwards Lifesciences Corporation
$37
Kiniksa Pharmaceuticals, Ltd.
$35
ViiV Healthcare Company
$34
Astellas Pharma US Inc
$31
Bayer HealthCare Pharmaceuticals Inc.
$29
PORTOLA PHARMACEUTICALS, INC.
$25
Terumo Medical Corporation
$25
iRhythm Technologies, Inc.
$25
SCPHARMACEUTICALS INC.
$23
Lundbeck LLC
$21
HeartFlow, Inc.
$21
EISAI INC.
$16
Top 3 companies account for 40.8% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ASSURITY · Allure Quadra RF CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · BELSOMRA · BRILINTA · CAMZYOS · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · CareLink · Carnation Ambulatory Monitor · Carto 3 · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DOVATO · Dayvigo · ELIQUIS · ENTRESTO · EVKEEZA · FARXIGA · FUROSCIX · GENERAL TACHY · Impella · JARDIANCE · JOT DX · Kerendia · LATITUDE · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · Myrbetriq · NORTHERA · NRG · NURTEC ODT · ONPATTRO · Otezla · Ozempic · PRALUENT · Repatha · SAMSCA · TR BAND · Temperature Management System · VERQUVO · VYNDAQEL · Vascepa · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
58
Per 100K population
1.8
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gandhi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gandhi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gandhi performed 991 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gandhi receive payments from pharmaceutical companies?
Yes. Dr. Gandhi received a total of $7,632 from 37 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gandhi's costs compare to other interventional cardiologists in Newport Beach?
Dr. Gandhi's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gandhi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Newport Beach
Browse interventional cardiologists in Newport Beach ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology